Westchester Capital Management (New York)’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Westchester Capital Management (New York)’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-978,893	Closed	-$45.5M	–	362
2023 Q2	$45.5M	Buy	+978,893	New	+$33.8M	1.43%	15

Westchester Capital Management (New York)'s DICE Position: Q3 2023 in Review

Westchester Capital Management (New York) sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 978,893 shares — an estimated $45.5M sold.

Westchester Capital Management (New York) first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $45.5M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Westchester Capital Management (New York) reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 978,893 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $45.5M.
Westchester Capital Management (New York) first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Westchester Capital Management (New York)'s DICE Therapeutics, Inc. Common Stock position peaked at $45.5M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2023, filed 8 Nov 2023.